Background:
Colon cancer is one of the major causes of morbidity and mortality worldwide. Cycle
inhibiting factors (Cifs) have been shown to deamidate Nedd8, resulting in cell cycle arrest.
Objective:
To determine the antitumor effect of Cifs on colon cancer by using attenuated Salmonella typhimurium
VNP20009.
Methods:
The VNP-SOPE2-cif and VNP-SOPE2-cif-C/A plasmids were transfected into attenuated Salmonella
typhimurium VNP20009. The efficiency and specificity of the Cif promoter were validated in colon cancer
SW480 cell lines. Western blotting was subsequently performed to evaluate cell cycle regulators, including P21,
P27 and Wee1. In vivo, the antitumor effect of VNP20009 was evaluated in a colon cancer xenograft model.
Results:
Firstly, VNP-SOPE2-cif and VNP-SOPE2-cif-C/A were selectively expressed both in the bacterial and
colon cancer cells. Cif expression in SW480 cells via the VNP tumor-targeted expression system induced the
accumulation of Wee1, p21 and p27 expression. Moreover, tumor growth was significantly inhibited in the mice
with VNP-SOPE2-cif compared to the mice with VNP with the empty construct.
Conclusion:
These results suggest that Cif gene delivered by VNP20009 is a promising approach for the
treatment of colon cancer.
In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model
